JP Stock MarketDetailed Quotes

4882 Perseus Proteomics

Watchlist
  • 405
  • -9-2.17%
20min DelayNot Open May 7 15:30 JST
5.97BMarket Cap-4.32P/E (Static)

About Perseus Proteomics Company

Perseus Proteomics Inc is engaged in the research and development, manufacture, and sales of pharmaceuticals. It provides antibody based therapeutics and diagnostics drugs to cure against cancer and other diseases.

Company Profile

Symbol4882
Company NamePerseus Proteomics
Founded2001-02-01
MarketTSE Growth
Fiscal Year Ends03-31
Address4-7-6, Komaba Tokyo Park Building, Meguro-ku
Zip Code103-0015
Phone03-6264-8268

Company Executives

  • Name
  • Position
  • Salary
  • Takuya Yokokawa
  • Representative Director, President and Executive Officer
  • --
  • Shinji Hagiwara
  • Director, Executive Officer and Head of Business Development Dept and Research and Development
  • --
  • Shinichi Suzukawa
  • Director, Executive Officer and Head of Administrative Dept
  • --
  • Tatsuya Nagase
  • Director
  • --
  • Takashi Ohno
  • Director
  • --
  • Tadashi Horiuchi
  • Independent Director
  • --
  • Nobuo Hanai
  • Independent Director
  • --
  • Kinichirou Kominami
  • Independent Director
  • --

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve Show More